Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

TransMedics Group, Inc.

TMDX Clue Score83
United States Fiscal year ends December CIK 0001756262 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
David Weill
11 Sep 2026
Director
Buy
1,336
$81.63
$109.06K
Waleed H Hassanein
17 Nov 2025
President & CEO
Buy indirect
8,775
$114.00
$1.00M
Waleed H Hassanein
7 Aug 2025
President & CEO
Buy indirect
1,858
$116.85
$217.11K
Waleed H Hassanein
7 Aug 2025
President & CEO
Buy indirect
6,617
$116.08
$768.10K
Waleed H Hassanein
6 Aug 2025
President & CEO
Buy indirect
8,400
$118.68
$996.91K
David Weill
29 Aug 2023
Director
Buy
2,500
$62.00
$155.00K
Showing 250 of 441 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 329
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 21
Sales straight out of an exercise 304
Sales at will 85
Transactions with no price 0
Shares from compensation/vesting 21,489,838
Sales filed before the plan box existed 46
History held since 6 May 2019